JA Gietema, DT Sleijfer, PHB Willemse, HS … - Annals of internal medicine, 1992 - Am Coll Physicians Results:The mean cholesterol level in patients at the start of chemotherapy was
3.96 ± 0.98 mmol/L [153 ± 38 mg/dL], increasing 4 to 6 years later to 6.12 ±
1.20 mmol/L [237 ± 46 mg/dL] (P < 0.001); 49 of 57 patients had an ... Cited by 58 - Related articles - All 3 versions
- ►ascopubs.org [PDF] M Boyer, D Raghavan, PJ Harris, J Lietch, A … - Journal of Clinical Oncology, 1990 - jco.ascopubs.org To date, the prevalence and nature of the late toxicity of cisplatin-based
combination chemotherapy for ad- vanced testicular cancer has been poorly
documented. Thirty men with a median age of 35 years (range, 23 to 63), who ... Cited by 71 - Related articles - All 6 versions
- ►ascopubs.org [PDF] D Raghavan, K Cox, A Childs, J Grygiel, D … - Journal of Clinical Oncology, 1992 - jco.ascopubs.org Purpose: The study was designed to determine pro- spectively the prevalence of
fasting serum lipid abnormal- ities in patients who were treated with
cisplatin-based chemotherapy for germ cell tumors. We unexpectedly had ... Cited by 64 - Related articles - All 7 versions
CC Berger, C Bokemeyer, F Schuppert, HJ … - British journal of cancer, 1996 - pubmedcentral.nih.gov Type and extent of endocrinological alterations were studied in long-term
disease-free survivors after cisplatin-based chemotherapy for testicular cancer.
A total of 63 patients with a median age of 30 (19-53) years, and median ... Cited by 39 - Related articles - BL Direct - All 4 versions
- ►ascopubs.org [PDF] CR Nichols, BJ Roth, SD Williams, I Gill, FM … - Journal of Clinical Oncology, 1992 - jco.ascopubs.org Purpose: The purpose of this study is to evaluate the risk of acute vascular
events in patients receiving cisplatin- based chemotherapy for testicular
cancer. Patients and Methods: A questionnaire assessing car- diovascular ... Cited by 49 - Related articles - All 6 versions
- ►ascopubs.org [PDF] C Bokemeyer, CC Berger, MA Kuczyk, HJ … - Journal of Clinical Oncology, 1996 - jco.ascopubs.org Purpose: The current study evaluates the extent and reversibility of late
sequelae after chemotherapy in long- term survivors of testicular cancer. The
influence of ther- apy and patient characteristics and the relationship be- ... Cited by 154 - Related articles - BL Direct - All 8 versions
D Bissett, L Kunkeler, L Zwanenburg, J Paul, … - British Journal of Cancer, 1990 - pubmedcentral.nih.gov Seventy-four patients previously treated in our department for germ cell tumour
of the testis underwent a series of tests to determine the frequency of
long-term therapeutic complications. All had received cisplatin-based ... Cited by 42 - Related articles - All 2 versions
J Nuver, AJ Smit, DT Sleijfer, AI van Gessel … - European Journal of Cancer, 2004 - Elsevier Testicular cancer patients have an increased risk for coronary artery disease
more than ten years after cisplatin-based chemotherapy. We investigated whether
vascular changes, including endothelial dysfunction, are present earlier. ... Cited by 32 - Related articles - All 12 versions
CC Berger, C Bokemeyer, M Schneider, MA … - European Journal of Cancer, 1995 - Elsevier 182 patients treated with cisplatin-based chemotherapy for testicular cancer at
Hannover University Medical School who were in complete remission (CR) for more
than 1 year after therapy were randomly selected for the evaluation of late ... Cited by 48 - Related articles - BL Direct - All 6 versions
- ►ascopubs.org MT Meinardi, JA Gietema, WTA Van der Graaf, … - Journal of Clinical Oncology, 2000 - jco.ascopubs.org PATIENTS AND METHODS: Eighty-seven patients treated with cisplatin-containing
chemotherapy before 1987 who were in remission for at least 10 years and whose
ages were 50 years at the time of analysis were evaluated for the ... Cited by 206 - Related articles - BL Direct - All 8 versions
